Bentham Science Logo

Track Your Manuscript:


CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 19, 10 Issues, 2020
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

CNS & Neurological Disorders - Drug Targets , Volume 18 - Number 2

Biography   Open Access


Review Article

New Drug Discovery from Medicinal Plants and Phytoconstituents for Depressive Disorders

, 18(2): 92 - 102

Fatma Tuğçe Gürağaç Dereli, Mert Ilhan and Esra Küpeli Akkol*


DOI: 10.2174/1871527317666181114141129



Review Article

A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases

, 18(2): 103 - 114

Jia Zhao*, Mengxia Zhu, Mukesh Kumar, Fung Yin Ngo, Yinghui Li, Lixing Lao and Jianhui Rong


DOI: 10.2174/1871527317666181105093834



Research Article

Xuesaitong May Protect Against Ischemic Stroke by Modulating Microglial Phenotypes and Inhibiting Neuronal Cell Apoptosis via the STAT3 Signaling Pathway

, 18(2): 115 - 123

Fangfang Li , Haiping Zhao, Ziping Han, Rongliang Wang, Zhen Tao, Zhibin Fan, Sijia Zhang, Guangwen Li, Zhigang Chen* and Yumin Luo*


DOI: 10.2174/1871527317666181114140340



Research Article

A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions

, 18(2): 124 - 140

Sunee Sirivichayakul, Buranee Kanchanatawan, Supaksorn Thika, André F. Carvalho and Michael Maes*


DOI: 10.2174/1871527317666181119115532



Research Article

Generation and Characterization of a Functional Nanobody Against Inflammatory Chemokine CXCL10, as a Novel Strategy for the Treatment of Multiple Sclerosis

, 18(2): 141 - 148

Tahereh Sadeghian-Rizi, Mahdi Behdani, Hossein Khanahmad, Hamid Mirmohammad Sadeghi and Ali Jahanian-Najafabadi*


DOI: 10.2174/1871527317666181114134518



Research Article

Cytarabine and Ferric Carboxymaltose (Fe+3) Increase Oxidative Damage and Alter Serotonergic Metabolism in Brain

, 18(2): 149 - 155

David Calderón Guzmán, Norma Osnaya Brizuela, Maribel Ortíz Herrera, Hugo Juárez Olguín*, Armando Valenzuela Peraza, Ernestina Hernández García, Francisca Trujillo Jiménez and Gerardo Barragán Mejía


DOI: 10.2174/1871527318666181128144343


Research Article

Effects of Exercise and Ferulic Acid on Alpha Synuclein and Neuroprotective Heat Shock Protein 70 in An Experimental Model of Parkinsonism Disease

, 18(2): 156 - 169

Mona H. Askar, Abdelaziz M. Hussein*, Soheir F. Al-Basiony, Refka K. Meseha, Emile F. Metias, Mohamed M. Salama, Ashraf Antar and Aya El-Sayed


DOI: 10.2174/1871527317666180816095707




Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)
Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Scopus CiteScore Metrics: 2.72

Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog